GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Novacyt SA (LSE:NCYT) » Definitions » Sale Of Business

Novacyt (LSE:NCYT) Sale Of Business : £0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Novacyt Sale Of Business?

Novacyt's sale of business for the six months ended in Dec. 2023 was £0.00 Mil. It means Novacyt gained £0.00 Mil from selling business. Novacyt's sale of business for the trailing twelve months (TTM) ended in Dec. 2023 was £0.00 Mil.

Compared with last quarter (£0.00 Mil in Jun. 2023 ), Novacyt gained the same money from selling business in Dec. 2023 (£0.00 Mil).

Novacyt Sale Of Business Historical Data

The historical data trend for Novacyt's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novacyt Sale Of Business Chart

Novacyt Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.32 - - - -

Novacyt Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.02 - - -

Novacyt Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novacyt Sale Of Business Related Terms

Thank you for viewing the detailed overview of Novacyt's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Novacyt (LSE:NCYT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Novacyt SA (LSE:NCYT) » Definitions » Sale Of Business
Comparable Companies
XPAR:AFME XPAR:ALMKT XPAR:ALTHE XPAR:ALTER XPAR:ALBLU XPAR:ALDMS XPAR:ALEMG XPAR:ALIKO XPAR:ALSGD XPAR:ALIMP ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
NVYTF:USA ALNOV:France NYZ:Germany
Address
13, Avenue Morane Saulnier, Velizy-Villacoublay, FRA, 78140
Website
https://www.novacyt.com
Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. The company operates its business through the following business segments. Primerdesign is the designer, manufacturer, and marketer of molecular 'real-time' qPCR testing devices and reagents in the areas of infectious diseases based in Southampton, UK: IT-IS International segment develops PCR devices for the life sciences and food testing industry and Corporate segment.

Novacyt (LSE:NCYT) Headlines

No Headlines